A Record Half, Concentrated in Fewer Hands

Digital health funding hit $8.9 billion across 389 deals in the first half of 2026, part of a broader digital health market on pace for $80.1 billion for the full year, up 14% versus 2025, according to Rock Health’s H1 2026 report. But the headline number hides a concentration trend: just twelve companies captured 59% of total quarterly funding, driven by a wave of $100 million-plus mega-rounds rather than broad-based deal growth.

Valuations have moved with the concentration. Median pre-money valuation reached $32.5 million, up from $22 million just two years earlier, while venture-growth valuations surged to a record $1.4 billion median, per Galen Growth’s Q1 2026 US digital health analysis. The US captured 76% of global digital health funding in that quarter, even as health overall still takes a smaller share of total US venture dollars (6.3%) than the global benchmark (8.0%).

AI Stopped Being a Differentiator

The more important shift is qualitative. AI now represents 46% of all healthcare investment, and AI-enabled companies captured 54% of all digital health funding — meaning a HealthTech startup without a credible AI story is now competing for a shrinking minority of available capital. That also means AI alone no longer distinguishes a pitch. Investors have moved the differentiation bar to what the AI actually changes inside a health system’s clinical or financial workflow.

Why Health System Sales Still Don't Follow SaaS Rules

None of this changes the structural reality that health systems buy differently than other enterprises. A hospital system is not one customer; it is a clinical governance board, a compliance office, a value-analysis committee, and often a separate IT security review, all of whom need to agree before a pilot becomes a purchase order. As a HealthTech venture capital investor, CIVC evaluates founders on whether they can clear the clinical, financial, and compliance gates in parallel — naming the budget owner and the renewal metric before the pilot even starts, not after the results come in.

What CIVC Looks For Now

Given how concentrated 2026 HealthTech capital has become in a small number of mega-rounds, CIVC looks for founders who can demonstrate a repeatable pilot-to-contract conversion process across multiple health systems, not a single flagship deployment. Through Corporate Intelligence™, CIVC connects HealthTech portfolio companies directly with health system partners who can pressure-test that path before a founder has spent a year finding out the hard way.